Select Medical Holdings Announces Estimate Of Certain Financial Results Of Its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc.; Q2 Net Operating Revenue To Be ~$477.9M, Q2 Income From Operations To Be ~$83.9M

7/12/24 4:33:18 PM ET

Hospital/Nursing Management

Health Care

Get the next $SEM alert in real time by email

Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced an estimate of certain financial results of its wholly-owned subsidiary, Concentra Group Holdings Parent, Inc. ("Concentra"), for the second quarter ended June 30, 2024 in advance of the announcement of Select Medical's actual results, which is expected to occur after market close on Thursday, August 1, 2024.

Select Medical expects Concentra's net operating revenue for its second quarter of 2024 to be approximately $477.9 million. Select Medical expects Concentra's income from operations for the second quarter of 2024 to be approximately $83.9 million. A summary of Concentra' estimated financial results is presented in table I of this release. Each item presented in table I is an estimation of the expectations (dollars in millions) for the second quarter of 2024. Certain key statistics are presented in table II of this release for the second quarters ended June 30, 2024 and 2023.

Get the next $SEM alert in real time by email

Date	Price Target	Rating	Analyst
8/20/2024	$42.00	Buy	BofA Securities
3/7/2022	$47.00 → $42.00	Outperform	RBC Capital
1/18/2022	$40.00 → $35.00	Buy	B of A Securities
1/18/2022	$50.00 → $47.00	Outperform	RBC Capital
8/10/2021	$37.00 → $39.00	Neutral	Credit Suisse

Select Medical Holdings Announces Estimate Of Certain Financial Results Of Its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc.; Q2 Net Operating Revenue To Be ~$477.9M, Q2 Income From Operations To Be ~$83.9M

Chat with this insight

Recent Analyst Ratings for $SEM

$SEM Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

BofA Securities resumed coverage on Select Medical with a new price target

RBC Capital reiterated coverage on Select Medical Holdings with a new price target

B of A Securities reiterated coverage on Select Medical Holdings with a new price target

$SEM SEC Filings

Select Medical Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

Select Medical Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Select Medical Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

$SEM Press Releases

Fastest customizable press release news feed in the world

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Select Medical Holdings Corporation Announces Distribution Ratio for Special Stock Distribution to Stockholders

Select Medical Holdings Corporation Announces Pricing of Offering of 6.250% Senior Notes due 2032 by Select Medical Corporation

$SEM Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

$SEM Financials

Live finance-specific insights

$SEM Market Insights

Live Market Insights

$SEM Leadership Updates

Live Leadership Updates

$SEM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Select Medical Holdings Corporation to Announce Third Quarter 2024 Results on Thursday, October 31, 2024

Select Medical Holdings Corporation Announces Estimate of Certain Financial Results of its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc. for the Second Quarter Ended June 30, 2024

Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024

Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share

A Glimpse Into The Expert Outlook On Select Medical Hldgs Through 4 Analysts

Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

Select Medical Holdings Corporation Announces Appointment of Katherine Davisson to its Board of Directors

EXECUTIVE VICE PRESIDENT Tarvin Michael E covered exercise/tax liability with 28,282 shares, decreasing direct ownership by 6% to 436,794 units (SEC Form 4)

CO-PRESIDENT Mullin Thomas P covered exercise/tax liability with 36,742 shares, decreasing direct ownership by 10% to 313,754 units (SEC Form 4)

Chief Information Officer Rusignuolo Brian R. covered exercise/tax liability with 25,690 shares, decreasing direct ownership by 8% to 301,050 units (SEC Form 4)

Recent Analyst Ratings for
$SEM

$SEM
Analyst Ratings

$SEM
SEC Filings

$SEM
Press Releases

$SEM
Large Ownership Changes

$SEM
Financials

$SEM
Market Insights

$SEM
Leadership Updates

$SEM
Insider Trading